Total Payments
$4,337
2024 Payments
$2,011
Companies
40
Transactions
221
Medicare Patients
12,045
Medicare Billing
$2.5M
Payment Breakdown by Category
Food & Beverage$4,256 (98.1%)
Education$81.31 (1.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,256 | 214 | 98.1% |
| Education | $81.31 | 7 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $547.54 | 28 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $319.80 | 16 | $0 (2024) |
| Janssen Biotech, Inc. | $319.59 | 19 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $260.06 | 16 | $0 (2024) |
| GENZYME CORPORATION | $255.18 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $241.61 | 11 | $0 (2024) |
| PFIZER INC. | $229.09 | 18 | $0 (2024) |
| Gilead Sciences, Inc. | $198.32 | 10 | $0 (2024) |
| SOBI, INC | $152.77 | 6 | $0 (2024) |
| Celgene Corporation | $146.05 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,011 | 96 | Novartis Pharmaceuticals Corporation ($248.29) |
| 2023 | $1,310 | 64 | Novartis Pharmaceuticals Corporation ($213.38) |
| 2022 | $262.77 | 15 | Amgen Inc. ($56.32) |
| 2021 | $23.29 | 1 | Seagen Inc. ($23.29) |
| 2020 | $50.55 | 3 | GENZYME CORPORATION ($21.81) |
| 2019 | $142.89 | 6 | Medtronic Vascular, Inc. ($67.66) |
| 2018 | $109.85 | 7 | PFIZER INC. ($45.75) |
| 2017 | $427.00 | 29 | PFIZER INC. ($107.26) |
All Payment Transactions
221 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: Oncology | ||||||
| 12/20/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $21.18 | General |
| Category: Hematology | ||||||
| 12/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.64 | General |
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: Oncology | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $14.80 | General |
| 11/18/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: Oncology | ||||||
| 11/15/2024 | GENZYME CORPORATION | ALTUVIIIO (Biological), ALPROLIX | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Hematology | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: ONCOLOGY | ||||||
| 11/01/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $31.38 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Oncology | ||||||
| 10/28/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $19.07 | General |
| 10/24/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $20.10 | General |
| Category: Hematology | ||||||
| 10/21/2024 | GENZYME CORPORATION | ALPROLIX (Biological), ALTUVIIIO | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Hematology | ||||||
| 10/21/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/18/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: ONCOLOGY | ||||||
| 10/14/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Oncology | ||||||
| 10/11/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Oncology | ||||||
| 10/07/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.46 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 50 | 2,887 | 72,863 | $4.0M | $779,001 |
| 2022 | 55 | 2,705 | 75,398 | $3.9M | $527,366 |
| 2021 | 58 | 3,104 | 72,092 | $3.6M | $584,946 |
| 2020 | 65 | 3,349 | 76,139 | $4.2M | $650,566 |
Total Patients
12,045
Total Services
296,492
Medicare Billing
$2.5M
Procedure Codes
228
All Medicare Procedures & Services
228 procedure records from CMS Medicare Utilization — Page 4 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96374 | Injection of drug or substance into vein | Office | 2022 | 29 | 63 | $15,561 | $1,872 | 12.0% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2022 | 26 | 84 | $13,524 | $1,825 | 13.5% |
| 82728 | Ferritin (blood protein) level | Office | 2022 | 73 | 115 | $6,900 | $1,553 | 22.5% |
| 71250 | Ct scan of chest without contrast | Office | 2022 | 27 | 27 | $18,522 | $1,202 | 6.5% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 22 | 50 | $7,250 | $1,181 | 16.3% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2022 | 13 | 13 | $7,280 | $1,002 | 13.8% |
| 83550 | Iron binding capacity | Office | 2022 | 73 | 114 | $3,990 | $987.44 | 24.7% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2022 | 38 | 153 | $5,202 | $977.29 | 18.8% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2022 | 28 | 169 | $72,839 | $935.82 | 1.3% |
| J1453 | Injection, fosaprepitant, 1 mg | Office | 2022 | 21 | 7,050 | $35,250 | $929.94 | 2.6% |
| 86300 | Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | Office | 2022 | 31 | 45 | $5,760 | $925.11 | 16.1% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2022 | 109 | 10,600 | $31,800 | $877.11 | 2.8% |
| 99195 | Drawing of blood for a medical problem | Office | 2022 | 11 | 13 | $3,402 | $855.61 | 25.2% |
| 70491 | Ct scan of soft tissue of neck with contrast | Office | 2022 | 14 | 14 | $9,212 | $845.09 | 9.2% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2022 | 17 | 31 | $7,936 | $814.99 | 10.3% |
| 83540 | Iron level | Office | 2022 | 73 | 114 | $3,078 | $730.90 | 23.7% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2022 | 47 | 106 | $3,286 | $633.94 | 19.3% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2022 | 30 | 720 | $82,080 | $581.44 | 0.7% |
| 85007 | Microscopic examination for white blood cells with manual cell count | Office | 2022 | 38 | 153 | $3,366 | $573.48 | 17.0% |
| 96523 | Irrigation of implanted venous access drug delivery device | Office | 2022 | 13 | 27 | $3,078 | $511.42 | 16.6% |
| J9045 | Injection, carboplatin, 50 mg | Office | 2022 | 13 | 172 | $51,600 | $368.76 | 0.7% |
| 96377 | Application of on-body injector for under skin injection | Office | 2022 | 11 | 24 | $2,304 | $353.79 | 15.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 54 | 1,680 | $1,680 | $157.51 | 9.4% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2022 | 25 | 74 | $1,406 | $155.54 | 11.1% |
| 85046 | Red blood count automated, with additional calculations | Office | 2022 | 23 | 24 | $624.00 | $132.30 | 21.2% |
About Dr. Nandita Rao, MD
Dr. Nandita Rao, MD is a Hematology & Oncology healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1669507372.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nandita Rao, MD has received a total of $4,337 in payments from pharmaceutical and medical device companies, with $2,011 received in 2024. These payments were reported across 221 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($4,256).
As a Medicare-enrolled provider, Rao has provided services to 12,045 Medicare beneficiaries, totaling 296,492 services with total Medicare billing of $2.5M. Data is available for 4 years (2020–2023), covering 228 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Plano, TX
- Active Since 02/22/2007
- Last Updated 12/11/2008
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1669507372
Products in Payments
- KEYTRUDA (Biological) $221.98
- KISQALI (Drug) $206.92
- DARZALEX (Biological) $168.02
- OPDIVO (Biological) $156.53
- Lenvima (Drug) $142.94
- BESREMI (Drug) $133.10
- OJJAARA (Drug) $132.15
- VERZENIO (Drug) $120.24
- LUMAKRAS (Drug) $113.05
- REBLOZYL (Biological) $102.97
- Enhertu (Drug) $96.67
- MEKINIST (Drug) $94.69
- IMFINZI (Biological) $86.44
- CABLIVI (Biological) $79.37
- DOPTELET (Drug) $77.40
- SARCLISA (Biological) $74.26
- ENHERTU (Biological) $67.92
- ClosureFast (Device) $67.66
- LYNPARZA (Drug) $63.66
- VONVENDI (Biological) $62.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Plano
Ruben Saez, Md, MD
Hematology & Oncology — Payments: $117,913
Hematology & Oncology $117,913
Deepna Jaiswal, D.o, D.O
Hematology & Oncology — Payments: $50,892
Hematology & Oncology $50,892
Dr. Thuy Le, M.d, M.D
Hematology & Oncology — Payments: $22,323
Hematology & Oncology $22,323
Andrew Kovoor, Md, MD
Hematology & Oncology — Payments: $13,233
Hematology & Oncology $13,233
Virginia Kinsella, Md, MD
Hematology & Oncology — Payments: $13,129
Hematology & Oncology $13,129
Dr. Wendy Mahone-Johnson, Md, MD
Hematology & Oncology — Payments: $8,818
Hematology & Oncology $8,818